Home/Racura Oncology/Dr Megan Baldwin
DM

Dr Megan Baldwin

Independent Non‑Executive Director

Racura Oncology

Therapeutic Areas

Racura Oncology Pipeline

DrugIndicationPhase
RC220Acute Myeloid Leukaemia (AML)Phase 3